Repositioning synthetic glucocorticoids in psychiatric disease associated with neural autoantibodies: a narrative review

Synthetic glucocorticoids (sGCs) are a well-investigated and standard drug therapy for disorders associated with CNS inflammation. Less is known about treating psychiatric disorders associated with neural autoantibodies. Our aim is to elucidate the repositioning of sGCs in psychiatric diseases that...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Niels, Neyazi, Alexandra, Lüdecke, Daniel, Hasan, Alkomiet, Wiltfang, Jens, Malchow, Berend
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Psychiatry and Preclinical Psychiatric Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374711/
https://www.ncbi.nlm.nih.gov/pubmed/36576564
http://dx.doi.org/10.1007/s00702-022-02578-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374711/
https://www.ncbi.nlm.nih.gov/pubmed/36576564
http://dx.doi.org/10.1007/s00702-022-02578-2

Ejemplares similares